Bristol-Myers Squibb (BMY) Reports Waiting Period to Acquire Amylin Pharmaceuticals (AMLN) Expired
Tweet Send to a FriendGet Alerts BMY Hot Sheet
Price: $47.48 +1.02%
Overall Analyst Rating:
NEUTRAL (
Up)
Dividend Yield: 3.4%
EPS Growth %: -35.9%
Overall Analyst Rating:
NEUTRAL (
Up)Dividend Yield: 3.4%
EPS Growth %: -35.9%
Trade BMY Now!
Bristol-Myers Squibb (NYSE: BMY) announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976, as amended (HSR), for its tender offer for Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) (“Amylin”) has expired.
Bristol-Myers Squibb initiated on July 10, 2012, through its wholly-owned subsidiary B&R Acquisition Company, a cash tender offer to purchase all outstanding shares of common stock of Amylin for $31.00 per share.
The expiration of the HSR waiting period satisfies one of the conditions to the tender offer, which will expire at 5:00 PM (New York City time) on Tuesday, August 7, 2012, unless extended in accordance with the merger agreement and the applicable rules and regulations of the SEC.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Bristol-Myers Squibb initiated on July 10, 2012, through its wholly-owned subsidiary B&R Acquisition Company, a cash tender offer to purchase all outstanding shares of common stock of Amylin for $31.00 per share.
The expiration of the HSR waiting period satisfies one of the conditions to the tender offer, which will expire at 5:00 PM (New York City time) on Tuesday, August 7, 2012, unless extended in accordance with the merger agreement and the applicable rules and regulations of the SEC.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Bausch & Lomb near deal to sell to Valeant Pharmaceuticals (VRX) - WSJ
- Jive Software (JIVE) 'In Play', But SAP Balks
- Iconix Brand Group (ICON) Buys Remaining Interest in IP Holdings
Create E-mail Alert Related Categories
Mergers and Acquisitions
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
